Drug repositioning based on similarity constrained probabilistic matrix factorization: COVID-19 as a case study
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Drug repositioning based on similarity constrained probabilistic matrix factorization: COVID-19 as a case study
Authors
Keywords
Drug–virus interactions prediction, Similarity constrained probabilistic matrix factorization, Drug repositioning, Drug–disease associations prediction, COVID-19
Journal
APPLIED SOFT COMPUTING
Volume -, Issue -, Pages 107135
Publisher
Elsevier BV
Online
2021-01-23
DOI
10.1016/j.asoc.2021.107135
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
- (2020) Manli Wang et al. CELL RESEARCH
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection
- (2020) Emmie de Wit et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Remdesivir as a possible therapeutic option for the COVID-19
- (2020) Jaffar A. Al-Tawfiq et al. Travel Medicine and Infectious Disease
- Broad Spectrum Antiviral Agent Niclosamide and Its Therapeutic Potential
- (2020) Jimin Xu et al. ACS Infectious Diseases
- A Computational Study of Potential miRNA-Disease Association Inference Based on Ensemble Learning and Kernel Ridge Regression
- (2020) Li-Hong Peng et al. Frontiers in Bioengineering and Biotechnology
- Of chloroquine and COVID-19
- (2020) Franck Touret et al. ANTIVIRAL RESEARCH
- Potential covalent drugs targeting the main protease of the SARS-CoV-2 coronavirus
- (2020) Sen Liu et al. BIOINFORMATICS
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Novel coronavirus treatment with ribavirin: Groundwork for an evaluation concerning COVID-19
- (2020) Jahan S. Khalili et al. JOURNAL OF MEDICAL VIROLOGY
- Compassionate Use of Remdesivir for Patients with Severe Covid-19
- (2020) Jonathan Grein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Drug treatment options for the 2019-new coronavirus (2019-nCoV)
- (2020) Hongzhou Lu BioScience Trends
- The COVID-19 Pandemic: A Comprehensive Review of Taxonomy, Genetics, Epidemiology, Diagnosis, Treatment, and Control
- (2020) Yosra A. Helmy et al. Journal of Clinical Medicine
- Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study
- (2020) Qingxian Cai et al. Engineering
- Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro
- (2020) Ka-Tim Choy et al. ANTIVIRAL RESEARCH
- Candidate drugs against SARS-CoV-2 and COVID-19
- (2020) Dwight L. McKee et al. PHARMACOLOGICAL RESEARCH
- Computational Model Development of Drug-Target Interaction Prediction: A Review
- (2019) Qi Zhao et al. CURRENT PROTEIN & PEPTIDE SCIENCE
- Drug repositioning based on bounded nuclear norm regularization
- (2019) Mengyun Yang et al. BIOINFORMATICS
- Drug repurposing: progress, challenges and recommendations
- (2018) Sudeep Pushpakom et al. NATURE REVIEWS DRUG DISCOVERY
- Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses
- (2017) Timothy P. Sheahan et al. Science Translational Medicine
- GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo- and Paramyxoviruses
- (2017) Michael K. Lo et al. Scientific Reports
- A comparative study of SMILES-based compound similarity functions for drug-target interaction prediction
- (2016) Hakime Öztürk et al. BMC BIOINFORMATICS
- Network Consistency Projection for Human miRNA-Disease Associations Inference
- (2016) Changlong Gu et al. Scientific Reports
- Protease inhibitors targeting coronavirus and filovirus entry
- (2015) Yanchen Zhou et al. ANTIVIRAL RESEARCH
- DrugNet: Network-based drug–disease prioritization by integrating heterogeneous data
- (2015) Víctor Martínez et al. ARTIFICIAL INTELLIGENCE IN MEDICINE
- The $2.6 Billion Pill — Methodologic and Policy Considerations
- (2015) Jerry Avorn NEW ENGLAND JOURNAL OF MEDICINE
- Why is Tanimoto index an appropriate choice for fingerprint-based similarity calculations?
- (2015) Dávid Bajusz et al. Journal of Cheminformatics
- Prediction of MicroRNA-Disease Associations Based on Social Network Analysis Methods
- (2015) Quan Zou et al. Biomed Research International
- Multi-targeted therapy of cancer by niclosamide: A new application for an old drug
- (2014) Yonghe Li et al. CANCER LETTERS
- Semi-supervised learning for potential human microRNA-disease associations inference
- (2014) Xing Chen et al. Scientific Reports
- MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability
- (2013) K. Katoh et al. MOLECULAR BIOLOGY AND EVOLUTION
- Molecular Docking: A Powerful Approach for Structure-Based Drug Discovery
- (2012) Xuan-Yu Meng et al. Current Computer-Aided Drug Design
- PREDICT: a method for inferring novel drug indications with application to personalized medicine
- (2011) A. Gottlieb et al. Molecular Systems Biology
- Open Babel: An open chemical toolbox
- (2011) Noel M O'Boyle et al. Journal of Cheminformatics
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More